Skip to main content

Table 7 Predicted DDI types of drug pairs

From: Multi-view feature representation and fusion for drug-drug interactions prediction

Drug a

Drug b

Interactions type

Evidence

Selexipag

Epoprostenol

Drug a may increase the hyperglycemic activities of Drug b

DrugBank

Selexipag

Fluconazole

Drug a may increase the neuromuscular blocking activities of Drug b

Unconfirmed

Vorapaxar

Amiodarone

Drug a may decrease the sedative activities of Drug b

DrugBank

Vorapaxar

Argatroban

The metabolism of Drug b can be decreased when combined with Drug a

DrugBank